Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: May 28, 2023. (Total: 217323Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 5 (of 5 Records)

Query Trace: Colorectal Neoplasms and meta-analysis and NRAS[original query]
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Jan 26 (1): 13-21.
Sorich M J, Wiese M D, Rowland A, Kichenadasse G, McKinnon R A, Karapetis C
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.
Acta oncologica (Stockholm, Sweden) 2014 Jul 53 (7): 852-64.
Therkildsen Christina, Bergmann Troels K, Henrichsen-Schnack Tine, Ladelund Steen, Nilbert M
Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.
World journal of gastroenterology 2016 Aug 22 (30): 6944-54.
Lo Nigro Cristiana, Ricci Vincenzo, Vivenza Daniela, Granetto Cristina, Fabozzi Teresa, Miraglio Emanuela, Merlano Marco
Efficacy of cetuximab-based chemotherapy in metastatic colorectal cancer according to RAS and BRAF mutation subgroups: A meta-analysis.
Molecular and clinical oncology 2016 Jun 4 (6): 1017-1024.
Lin L I, Chen Lu-Lu, Wang You, Meng Xiang-Yu, Liang Chen, Zhou Fu-Xia
A Systematic Literature Review and Meta-Analysis Describing the Prevalence of KRAS, NRAS, and BRAF Gene Mutations in Metastatic Colorectal Cancer.
Gastroenterology research 2020 11 13 (5): 184-198.
Levin-Sparenberg Elizabeth, Bylsma Lauren C, Lowe Kimberly, Sangare Laura, Fryzek Jon P, Alexander Dominik
TOP